Cargando…
Complement and coagulation cascades pathway-related signature as a predictor of immunotherapy in metastatic urothelial cancer
Background: Immune checkpoint inhibitors (ICIs) have shown efficacy in patients with metastatic urothelial cancer (mUC), however, only a small subset of patients could benefit from ICIs. Identifying predictive biomarkers of ICIs in patients with mUC is clinical meaningful for patient stratification...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564431/ https://www.ncbi.nlm.nih.gov/pubmed/37747262 http://dx.doi.org/10.18632/aging.205022 |